Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2011 Nov 16:11:313.
doi: 10.1186/1472-6963-11-313.

Implementation of patient education at first and second dispensing of statins in Dutch community pharmacies: the sequel of a cluster randomized trial

Caroline H P A Van de Steeg-van Gompel  1 , Michel Wensing, Peter A G M De Smet
Affiliations
Randomized Controlled Trial

Implementation of patient education at first and second dispensing of statins in Dutch community pharmacies: the sequel of a cluster randomized trial

Caroline H P A Van de Steeg-van Gompel et al. BMC Health Serv Res. .

Abstract

Background: As a result of the previous part of this trial, many patients with cardiovascular disease were expected to receive a statin for the first time. In order to provide these patients with comprehensive information on statins, as recommended by professional guidance, education at first and second dispensing of statins had to be implemented. This study was designed to assess the effectiveness of an intensive implementation program targeted at pharmacy project assistants on the frequency of providing education at first dispensing (EAFD) and education at second dispensing (EASD) of statins in community pharmacies.

Methods: The participating community pharmacies were clustered on the basis of local collaboration, were numbered by a research assistant and subsequently an independent statistician performed a block randomization, in which the cluster size (number of pharmacies in each cluster) was balanced. The pharmacies in the control group received a written manual on the implementation of EAFD and EASD; the pharmacies in the intervention group received intensive support for the implementation. The impact of the intensive implementation program on the implementation process and on the primary outcomes was examined in a random coefficient logistic regression model, which took into account that patients were grouped within pharmacy clusters.

Results: Of the 37 pharmacies in the intervention group, 17 pharmacies (50%) provided EAFD and 12 pharmacies (35.3%) provided EASD compared to 14 pharmacies (45.2%, P = 0.715) and 12 pharmacies (38.7%, P = 0.899), respectively, of the 34 pharmacies in the control group. In the intervention group a total of 72 of 469 new statin users (15.4%) received education and 49 of 393 patients with a second statin prescription (12.5%) compared to 78 of 402 new users (19.4%, P = 0.944) and 35 of 342 patients with a second prescription (10.2%, P = 0.579) in the control group.

Conclusion: The intensive implementation program did not increase the frequency of providing EAFD and EASD of statins in community pharmacies.

Trial registration: clinicaltrials.gov NCT00509717.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Participant flow.
See this image and copyright information in PMC

References

    1. van de Steeg-van Gompel CH, Wensing M, De Smet PA. Implementation of a pharmacist-led intervention to enhance statin prescribing for secondary prevention in primary care: a cluster randomized trial. Eur J Cardiovasc Prev Rehabil. 2011. in press . - PubMed
    1. KNMP. Nederlandse Apotheek Norm (NAN) 2006. Richtlijn 2: Farmaceutische zorg- en dienstverlening. http://www.knmp.nl/organisatie-regelgeving/normen-en-richtlijnen/normen/... Last accessed: June 28 2011.
    1. Puspitasari HP, Aslani P, Krass I. A review of counseling practices on prescription medicines in community pharmacies. Res Social Adm Pharm. 2009;5:197–210. doi: 10.1016/j.sapharm.2008.08.006. - DOI - PubMed
    1. Liberopoulos EN, Florentin M, Mikhailidis DP, Elisaf MS. Compliance with lipid-lowering therapy and its impact on cardiovascular morbidity and mortality. Expert Opin Drug Saf. 2008;7:717–725. doi: 10.1517/14740330802396984. - DOI - PubMed
    1. Bates TR, Connaughton VM, Watts GF. Non-adherence to statin therapy: a major challenge for preventive cardiology. Expert Opin Pharmacother. 2009;10:2973–2985. doi: 10.1517/14656560903376186. - DOI - PubMed

Publication types

MeSH terms

Substances

Associated data